191 related articles for article (PubMed ID: 31823769)
1. ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions.
Mantani PT; Dunér P; Ljungcrantz I; Nilsson J; Björkbacka H; Fredrikson GN
BMC Immunol; 2019 Dec; 20(1):47. PubMed ID: 31823769
[TBL] [Abstract][Full Text] [Related]
2. IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice.
Mantani PT; Dunér P; Bengtsson E; Alm R; Ljungcrantz I; Söderberg I; Sundius L; To F; Nilsson J; Björkbacka H; Fredrikson GN
PLoS One; 2015; 10(1):e0117255. PubMed ID: 25629516
[TBL] [Abstract][Full Text] [Related]
3. Type 2 innate lymphoid cells regulation by regulatory T cells attenuates atherosclerosis.
Gao X; Lin J; Zheng Y; Liu S; Liu C; Liu T; Wang B; He S; Li D
J Mol Cell Cardiol; 2020 Aug; 145():99-111. PubMed ID: 32526223
[TBL] [Abstract][Full Text] [Related]
4. The Prostaglandin D
Oyesola OO; Duque C; Huang LC; Larson EM; Früh SP; Webb LM; Peng SA; Tait Wojno ED
J Immunol; 2020 Feb; 204(4):1001-1011. PubMed ID: 31900341
[TBL] [Abstract][Full Text] [Related]
5. Expansion of CD25+ Innate Lymphoid Cells Reduces Atherosclerosis.
Engelbertsen D; Foks AC; Alberts-Grill N; Kuperwaser F; Chen T; Lederer JA; Jarolim P; Grabie N; Lichtman AH
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2526-35. PubMed ID: 26494229
[TBL] [Abstract][Full Text] [Related]
6. Targeting androgen signaling in ILC2s protects from IL-33-driven lung inflammation, independently of KLRG1.
Blanquart E; Mandonnet A; Mars M; Cenac C; Anesi N; Mercier P; Audouard C; Roga S; Serrano de Almeida G; Bevan CL; Girard JP; Pelletier L; Laffont S; Guéry JC
J Allergy Clin Immunol; 2022 Jan; 149(1):237-251.e12. PubMed ID: 33964300
[TBL] [Abstract][Full Text] [Related]
7. Type-2 innate lymphoid cells control the development of atherosclerosis in mice.
Newland SA; Mohanta S; Clément M; Taleb S; Walker JA; Nus M; Sage AP; Yin C; Hu D; Kitt LL; Finigan AJ; Rodewald HR; Binder CJ; McKenzie ANJ; Habenicht AJ; Mallat Z
Nat Commun; 2017 Jun; 8():15781. PubMed ID: 28589929
[TBL] [Abstract][Full Text] [Related]
8. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice.
Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D
J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469
[TBL] [Abstract][Full Text] [Related]
9. Natural killer (NK) cells augment atherosclerosis by cytotoxic-dependent mechanisms.
Selathurai A; Deswaerte V; Kanellakis P; Tipping P; Toh BH; Bobik A; Kyaw T
Cardiovasc Res; 2014 Apr; 102(1):128-37. PubMed ID: 24469537
[TBL] [Abstract][Full Text] [Related]
10. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis.
Chen WY; Wu YH; Tsai TH; Li RF; Lai AC; Li LC; Yang JL; Chang YJ
Theranostics; 2021; 11(6):2594-2611. PubMed ID: 33456562
[No Abstract] [Full Text] [Related]
11. Group 2 innate lymphoid cells promote TNBC lung metastasis via the IL-13-MDSC axis in a murine tumor model.
Zhao N; Zhu W; Wang J; Liu W; Kang L; Yu R; Liu B
Int Immunopharmacol; 2021 Oct; 99():107924. PubMed ID: 34217145
[TBL] [Abstract][Full Text] [Related]
12. A Proinflammatory Role of Type 2 Innate Lymphoid Cells in Murine Immune-Mediated Hepatitis.
Neumann K; Karimi K; Meiners J; Voetlause R; Steinmann S; Dammermann W; Lüth S; Asghari F; Wegscheid C; Horst AK; Tiegs G
J Immunol; 2017 Jan; 198(1):128-137. PubMed ID: 27872212
[TBL] [Abstract][Full Text] [Related]
13. Increased atherosclerotic lesions and Th17 in interleukin-18 deficient apolipoprotein E-knockout mice fed high-fat diet.
Pejnovic N; Vratimos A; Lee SH; Popadic D; Takeda K; Akira S; Chan WL
Mol Immunol; 2009 Nov; 47(1):37-45. PubMed ID: 19201478
[TBL] [Abstract][Full Text] [Related]
14. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
[TBL] [Abstract][Full Text] [Related]
15. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
[TBL] [Abstract][Full Text] [Related]
16. Systemic administration of IL-33 induces a population of circulating KLRG1
Guillerey C; Stannard K; Chen J; Krumeich S; Miles K; Nakamura K; Smith J; Yu Y; Ng S; Harjunpää H; Teng MW; Engwerda C; Belz GT; Smyth MJ
Immunol Cell Biol; 2021 Jan; 99(1):65-83. PubMed ID: 32748462
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice.
Danzaki K; Matsui Y; Ikesue M; Ohta D; Ito K; Kanayama M; Kurotaki D; Morimoto J; Iwakura Y; Yagita H; Tsutsui H; Uede T
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):273-80. PubMed ID: 22116098
[TBL] [Abstract][Full Text] [Related]
18. IL-17-producing ST2
Cai T; Qiu J; Ji Y; Li W; Ding Z; Suo C; Chang J; Wang J; He R; Qian Y; Guo X; Zhou L; Sheng H; Shen L; Qiu J
J Allergy Clin Immunol; 2019 Jan; 143(1):229-244.e9. PubMed ID: 29625134
[TBL] [Abstract][Full Text] [Related]
19. Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction.
Rigas D; Lewis G; Aron JL; Wang B; Banie H; Sankaranarayanan I; Galle-Treger L; Maazi H; Lo R; Freeman GJ; Sharpe AH; Soroosh P; Akbari O
J Allergy Clin Immunol; 2017 May; 139(5):1468-1477.e2. PubMed ID: 27717665
[TBL] [Abstract][Full Text] [Related]
20. Type 1 innate lymphoid cell aggravation of atherosclerosis is mediated through TLR4.
Wu C; He S; Liu J; Wang B; Lin J; Duan Y; Gao X; Li D
Scand J Immunol; 2018 May; 87(5):e12661. PubMed ID: 29570822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
